Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...

This revealed an astrocyte-driven upregulation of the levels of C1q complement protein mRNA ... molecular contributors to immune- and nervous-system function. Future work will unpick the links ...

Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...